SINERGY SEMINAR SERIES: Quantum Computing – New Horizons in Biological Research

Abstract:

The emerging field of quantum computing holds transformative potential for the future of scientific discovery. In this talk, we will explore the fundamentals of quantum computing and its promise to revolutionize biological research, offering unprecedented computational power and novel problem-solving techniques.

We will begin with an introduction to the basics of quantum computing, demystifying concepts like qubits, superposition, and entanglement that enable novel means to solve otherwise intractable computational challenges. Next, we’ll delve into practical applications, illustrating how quantum algorithms can accelerate Biology research. We will highlight early applications including complex simulations of molecular structures, drug discovery and development, bioinformatics data analysis, protein folding, gene regulatory network modeling, drug discovery and development, mechanobiology, RNA folding, and more.

While quantum computers are still in their early days, they promise, over the next decade, to overcome current limitations in classical computational methods. This talk aims to inspire and equip Biologists with the knowledge to envision the integration of quantum technologies into their own research, fostering a collaborative future where Quantum and Biological sciences intersect. Join us to discover how quantum computing can unlock new dimensions in understanding life at the molecular level and beyond.

Join us in our seminar series and a time of lunch networking!

Speakers’ bio:

Rebecca Krauthamer graduated from the Symbolic Systems Program at Stanford Univeristy. She was listed under Forbes 30 Under 30, 2020 in Science and is on the World Economic Forum’s Global Futures Council on the Quantum Economy. She is the founding CEO for the companies Quantum Thought and Quantum Computing Venture Studio. Currently, she is on the Advisory Board of the AI Ethics Journal and a contributing writer for the Newsweek.

Garrison Buss is a PhD graduate in Molecular & Cellular Physiology, 2022 from Stanford University. Garrison’s career has led him to executive positions as General Partner at Superposition Venture Capital, the first Quantum Computing Venture fund in the US, and COO at Carbonoo. He is listed on Silicon Valley Business Journal’s 40 Under 40, 2024.

Date: 9th July 2024

Time: 4.30pm – 5.30pm (SGT)

Location: CeLS Auditorium, 28 Medical Drive, #01-07 S117456

Location